Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer [Phase 2]
Phase 2 clinical trial results for hypofractionation proton beam therapy with concurrent treatment of prostate and pelvic nodes in prostate …
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer [Phase 2]
Phase 2 clinical trial evaluating ONM-100 as an intraoperative fluorescence imaging agent for cancer detection has completed enrollment with…
-
CLINICAL_TRIALS withdrawal · 2023-06-29Clinical Trial Update: BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy [Phase 3]
Phase 3 trial BioDFence G3 for full nerve-sparing robotic-assisted radical prostatectomy was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis [Phase 2]
A Phase 2 trial evaluating radioablation with or without androgen deprivation therapy in oligometastatic prostate cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: 2 Ablative RadioTherapy Treatments for Prostate Cancer [Phase 2, Phase 3]
Clinical trial update for two ablative radiotherapy treatments in prostate cancer across Phase 2 and Phase 3, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer [Phase 2]
Phase 2 trial evaluating GTx-758 effects on total and free testosterone in men with prostate cancer; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial update for a PSA vaccine therapy in patients with advanced prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 clinical trial evaluating chemotherapy with or without biological therapy in metastatic prostate cancer unresponsive to hormone ther…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) [Phase 3]
Phase 3 trial comparing pembrolizumab plus docetaxel to placebo plus docetaxel in chemotherapy-naïve metastatic castration-resistant prostat…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer [Phase 3]
Phase 3 extension study assessing long-term safety and tolerability of degarelix in Chinese patients with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 trial comparing hormone therapy to combination chemotherapy in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer [Phase 3]
Phase 3 trial evaluating epoetin alfa with or without dexamethasone for fatigue and anemia in hormone-refractory prostate cancer has complet…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: PET/MRI in Patients With Suspected Prostate Cancer [Phase 3]
Phase 3 trial evaluating PET/MRI in suspected prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel plus estramustine for metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) [Phase 3]
Phase 3 clinical trial for prostate cancer prevention in men with high-grade prostatic intraepithelial neoplasia has completed; results post…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Clinical Outcomes for Offering Genetic Testing in a Tiered Approach [NA]
A completed clinical trial evaluating the outcomes of offering genetic testing in a tiered approach, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy [Phase 2]
Phase 2 trial evaluating bicalutamide and dutasteride versus standard care for prostate cytoreduction prior to brachytherapy in prostate can…
-
FDA approval · 2023-05-31FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP, resulting in changes to the product…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Study Evaluating the Safety and Tolerability of L-377202 [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and tolerability of L-377202 in hormone refractory and standard prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating 68Ga-RM2 PET/CT for detecting regional nodal and distant metastases in intermediate/high-risk prostate cancer; resu…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: VMAT for Dominant Intraprostatic Lesion [NA]
Clinical trial update reporting completion of a study evaluating VMAT for a dominant intraprostatic lesion in prostate cancer, with results …
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Muscadine Plus (MPX) In Men With Prostate Cancer [Phase 3]
Phase 3 clinical trial of Muscadine Plus (MPX) in men with prostate cancer was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 [Phase 2]
Phase II study evaluating an adenovirus PSA vaccine in men with recurrent prostate cancer after local therapy has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating LHRH analogue therapy in combination with enzalutamide or bicalutamide for hormone-sensitive prostate ca…